Literature DB >> 29068242

Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.

Shalini Patlolla1, Suresh Vaikkakara1, Alok Sachan1, Ashok Venkatanarasu1, Bharath Bachimanchi1, Aparna Bitla2, Sarala Settipalli3, Sumathi Pathiputturu1, Roopa Naik Sugali1, Sravani Chiri1.   

Abstract

BACKGROUND: Insulin resistance and obesity are not universal features of polycystic ovary syndrome (PCOS). We planned to assess the differences between patients with nonobese /insulin-sensitive phenotype vs. obese/ insulin-resistant phenotype in terms of the potential mechanisms underlying their hyperandrogenism.
MATERIALS AND METHODS: A total of 52 women satisfying Androgen Excess Society (AES) criteria were included. Hormonal and metabolic profile including prolactin, dehydroepiandrosterone sulfate (DHEAS), free testosterone, sex hormone binding globulin (SHBG), fasting plasma glucose and insulin were measured in follicular phase.
RESULTS: DHEAS was found to be higher in the nonobese patients as compared to the obese (p = 0.01). There was also a strong trend for a higher DHEAS among patients with lower insulin resistance by homeostatic model assessment (HOMA-IR< 2.3) (p = .06).While the total testosterone (p = .044) and SHBG (p = .007) were found to be lower in the more insulin-resistant group (HOMA-IR ≥ 2.3), the free testosterone levels were similar. However, the percentage of free testosterone was higher in the more insulin-resistant group (p = .005).
CONCLUSIONS: The hyperandrogenic state in PCOS appears to have heterogenous origins. Nonobese patients with PCOS have adrenal hyperandrogenism as the underlying mechanism while their obese/ insulin-resistant counterparts have low SHBG and hence an increased fraction of free testosterone.

Entities:  

Keywords:  Adrenal hyperandrogenism; DHEAS; PCOS; insulin resistance; obesity

Mesh:

Substances:

Year:  2017        PMID: 29068242     DOI: 10.1080/09513590.2017.1393062

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome.

Authors:  Can Wang; Yang-Xing Wen; Qing-Yun Mai
Journal:  Exp Ther Med       Date:  2022-01-14       Impact factor: 2.447

Review 2.  Skin and metabolic syndrome: A review of the possible associations.

Authors:  Neda Adibi; Reza M Robati
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

3.  LKB1 suppresses androgen synthesis in a mouse model of hyperandrogenism via IGF-1 signaling.

Authors:  Ying Xu; Yongxing Gao; Zufang Huang; Yan Zheng; Wenjuan Teng; Deyan Zheng; Xiaohua Zheng
Journal:  FEBS Open Bio       Date:  2019-09-12       Impact factor: 2.693

Review 4.  Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.

Authors:  Sarantis Livadas; Panagiotis Anagnostis; Julia K Bosdou; Dimitra Bantouna; Rodis Paparodis
Journal:  World J Diabetes       Date:  2022-01-15

Review 5.  Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.

Authors:  Ellie C Stefanadi; Georgios Dimitrakakis; Christos-Konstantinos Antoniou; Dimitrios Challoumas; Nikita Punjabi; Inetzi Aggeliki Dimitrakaki; Sangeeta Punjabi; Christodoulos I Stefanadis
Journal:  Diabetol Metab Syndr       Date:  2018-02-21       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.